FOXP3 and liver disorder: We propose that the increased secretion of miR-122 observed in patients with liver diseases [44] may lead to the downregulation of FOXP3-associated targets in Treg, ths contributing to the establishment of a pro-inflammatory milieu in the liver, as reported for miR-122 KO mice [4] and human liver organoids [7].